Welcome guest, Login | Register

Home

X
加载中

Hepatitis C virus (HCV) is the main causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Since the HCV genome is present exclusively in RNA form during replication, a number of anti-HCV drugs show appearance of rapid drug-resistant viruses. Therefore, it is important to test generation of drug-escape mutant viruses by developed antiviral drugs for their validity. Here, we describe a colony formation assay-based method to observe appearance of drug-resistant viruses against nucleic acid based anti-HCV drugs in genotype 1b based subgenomic replicon cell culture system (Lee et al., 2013).

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Colony Forming Assay for HCV-Replicon Cell Line

Microbiology > Microbial genetics > Mutagenesis
Authors: Chang Ho Lee
Chang Ho LeeAffiliation: Molecular Biology Department, Dankook University, Yongin, Republic of Korea
Bio-protocol author page: a1080
 and Seong-Wook Lee
Seong-Wook LeeAffiliation: Molecular Biology Department, Dankook University, Yongin, Republic of Korea
For correspondence: swl0208@dankook.ac.kr
Bio-protocol author page: a1081
Vol 3, Iss 24, 12/20/2013, 2433 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1009

[Abstract] Hepatitis C virus (HCV) is the main causative agent of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Since the HCV genome is present exclusively in RNA form during replication, a number of anti-HCV drugs show appearance of rapid drug-resistant viruses. Therefore, it is important to test generation of drug-escape mutant viruses by developed antiviral drugs for their validity. Here, we describe a colony formation assay-based method to observe appearance of drug-resistant viruses against nucleic acid based anti-HCV drugs in genotype 1b based subgenomic replicon cell culture system (Lee et al., 2013).

Keywords: HEPATITIS C VIRUS, REPLICON, Colony forming assay

Materials and Reagents

  1. Cell line: HCV-replicon Huh-7 human hepatoma cell line (HCV genotype 1b subgenomic replicon pFKI389neo/NS3–3’/5.1 containing the neomycin resistant gene, provided by R. Bartenschlager, Heidelberg University, German) (Lohmann et al., 1999; Krieger et al., 2001)
  2. 0.1% Trypsin-EDTA (WELGENE, catalog number: LS015-01)
  3. Fetal Bovine Serum (FBS) (Thermo Fisher Scientific, HycloneTM, catalog number: SH30919.03)
  4. 100x Penicillin/Streptomycin solution (Thermo Fisher Scientific, HycloneTM, catalog number: 3V30010)
  5. Lipofectamine 2000 (Life Technology, catalog number: 11668-019)
  6. NaCl (Sigma-Aldrich, catalog number: S5886)
  7. KCl (Sigma-Aldrich, catalog number: P5405)
  8. Na2HPO4 (Sigma-Aldrich, catalog number: S3264)
  9. KH2PO4 (Sigma-Aldrich, catalog number: P9791)
  10. NaOH (Sigma-Aldrich, catalog number: S5881)
  11. 1x Phosphate Buffered Saline (PBS) (see Recipes)
  12. Complete Dulbecco’s modified Eagle medium with high glucose (DMEM) (Thermo Fisher Scientific, HycloneTM, catalog number: SH30243.01) (see Recipes)
  13. 50 mg/ml G418 (Merck KGaA, catalog number: 345810) (see Recipes)
  14. 2% Paraformaldehyde solution (Sigma-Aldrich, catalog number: 158127) (see Recipes)
  15. 1% Methylene blue (Duksan Scientific, catalog number: MEE0-22002) (see Recipes)

Equipment

  1. 35 mm cell culture plate (Corning, catalog number: 430165)
  2. 100 mm cell culture plate (BD Bioscience, catalog number: 353003)
  3. 5% CO2, 37 °C Incubator (Thermo Fisher Scientific, catalog number: 311)

Procedure

  1. Day one: HCV-replicon cells are sub-cultured and are seeded on 35 mm cell culture dish at density of 2 x 105 in 2 ml of complete DMEM.
  2. Day two: Before transfection, media was replaced with DMEM not containing Penicillin/Streptomycin.
  3. 4 μM of test or control nucleic acid-based drugs were transfected using Lipofectamine 2000 reagent according to manufacturer's instruction.
  4. Four hours after transfection, cells were replaced with 2 ml of fresh complete DMEM containing 500 μg/ml G418, and incubated for 2 days.
  5. Step 2 to step 4 was repeated every 2 day during about two weeks.
  6. About two weeks later, cells were trypsinized and sub-cultured, and one-tenth of the cells were replated to 35 mm dishes with 2 ml of 500 μg/ml G418 containing complete DMEM.
  7. Step 2 to step 6 was repeated until visible colonies were obtained (usually, colonies formed one month after first transfection).
  8. After acquiring colonies, media was removed and cells were washed 1 time with 1ml of 1x PBS.
  9. Cells were treated with 1 ml of 2% paraformaldehyde for 15 min at room temperature.
  10. Remove the paraformaldehyde from the cells and add 1 ml of 1% methylene blue for 10 min.
  11. Remove the methylene blue and wash cells with 1 ml of dH2O three times.
  12. Cells were air-dried for 15 min, and analyze appearance of drug-resistant cells by counting the number of G418-resistant cell colonies. You can find examples of picture showing drug-resistant colonies in the Figure 4C of Reference 1 (Lee et al., 2013).

Recipes

  1. 1x PBS
    137 mM NaCl
    2.7 mM KCl
    10 mM Na2HPO4
    2 mM KH2PO4
    Add dH2O to 1 L and sterilize using autoclave
  2. Complete DMEM medium (505 ml)
    50 ml FBS
    5 ml 100x Penicillin/Streptomycin solution
    450 ml DMEM
  3. 50 mg/ml G418
    1 g G418 powder
    Add dH2O to 20 ml and filter (0.45 μm) for sterilization
    Aliquote
    Store at -20 °C
  4. 2% Paraformaldehyde solution (15 ml)
    0.3 g paraformaldehyde
    75 μl 10 N NaOH
    Add to dH20 to 13.5 ml and incubate 60 °C until paraformaldehyde is dissolved
    Add 1.5 ml of 10x PBS and store at 4 °C
  5. 1% methylene blue (15 ml)
    0.15 g methylene blue
    Add to dH2O to 15 ml

Acknowledgments

This protocol was adapted from Lee et al. (2013). Funding Source included grants from the Korea Healthcare Technology R&D Project by the Korean Ministry for Health, Welfare & Family Affairs (A100399) and National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012M3A9B6055200).

References

  1. Krieger, N., Lohmann, V. and Bartenschlager, R. (2001). Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J Virol 75(10): 4614-4624. 
  2. Lee, C. H., Lee, Y. J., Kim, J. H., Lim, J. H., Kim, J. H., Han, W., Lee, S. H., Noh, G. J. and Lee, S. W. (2013). Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase. J Virol 87(12): 7064-7074.
  3. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L. and Bartenschlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285(5424): 110-113. 


How to cite this protocol: Lee, C. H. and Lee, S. (2013). Colony Forming Assay for HCV-Replicon Cell Line. Bio-protocol 3(24): e1009. DOI: 10.21769/BioProtoc.1009; Full Text



Reproducibility Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook